Overview of Treatment Approaches in Advanced CTCL
Lauren C. Pinter-Brown, MD, FACP, of UCI Health and Chao Family Comprehensive Cancer Center, described what advanced cutaneous T cell lymphoma is in terms of classification and what current treatment approaches are available.
Pharmacy Times interviewed Lauren C. Pinter-Brown, MD, FACP, professor in the Department of Dermatology and the Department of Medicine in the Division of Hematology and Oncology at UCI Health and Chao Family Comprehensive Cancer Center, on her recent presentation at the Society of Hematologic Oncology Annual Meeting (SOHO) 2021 conference on the treatment of advanced cutaneous T cell lymphoma (CTCL) in 2021.
During this discussion, Pinter-Brown addressed and described what advanced CTCL is in terms of classification and what current treatment approaches are available.
